Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 58 Records) |
Query Trace: Neoplasms and meta-analysis and MDM2[original query] |
---|
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
Association between murine double minute 2 T309G polymorphism and risk of liver cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Nov 35 (11): 11353-7. Tang Tao, Song Xin, Yang Zhiying, Huang Linping, Wang Wenyue, Tan Haido |
MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: meta-analysis of 15 studies. The Journal of international medical research 2014 Oct 42 (5): 1065-76. Shen Wei, Hu Ping, Cao Jia-qing, Liu Xiu-xia, Shao Jiang-h |
The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2014 15 (13): 5277-81. Wang Huai-Gao, Wu Qing-Yun, Zhou Hui, Peng Xin-Sheng, Shi Meng-Jie, Li Jie-Mei, Zhou Yan-Fa |
MDM2 SNP309 polymorphism is associated with colorectal cancer risk. Scientific reports 2014 4 4851. Wang Weizhi, Du Mulong, Gu Dongying, Zhu Lingjun, Chu Haiyan, Tong Na, Zhang Zhengdong, Xu Zekuan, Wang Meil |
Common variant on MDM2 contributes to endometrial cancer susceptibility: evidence based on 7 studies. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Aug 35 (8): 7555-60. Zhao Yan, Yang Xiaoer, Hao Xiaojiao, Pan Xiaolin, Zhao Bo, Ma Jingwen, Fang Jian, Zhao Mingho |
Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls. Therapeutics and clinical risk management 2014 10 269-77. Gao Jie, Kang An-Jing, Lin Shuai, Dai Zhi-Jun, Zhang Shu-Qun, Liu Di, Zhao Yang, Yang Peng-Tao, Wang Meng, Wang Xi-Ji |
MDM2 SNP309 variation confers the susceptibility to hepatocellular cancer: a meta-analysis based on 4271 subjects. International journal of clinical and experimental medicine 2015 8 (4): 5822-30. Lv Jinli, Zhu Bo, Zhang Liang, Xie Qichao, Zhuo Wenl |
Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis. OncoTargets and therapy 2015 8 3679-90. Xie Linguo, Sun Yan, Chen Tao, Tian Dawei, Li Yujuan, Zhang Yu, Ding Na, Shen Zhonghua, Xu Hao, Nian Xuewu, Sha Nan, Han Ruifa, Hu Hailong, Wu Chang |
Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis. Medical science monitor : international medical journal of experimental and clinical research 2016 22 3186-90. Xue Zhuowei, Zhu Xiaolu, Teng Yinche |
Association of MDM2 promoter T309G polymorphism with oral cancer risk: A meta-analysis of 3,536 subjects. Molecular and clinical oncology 2016 Jul 5 (1): 175-180. Yang X I, Zhu Yun, Ye Dongxia, Liu Yang, Sun Hongying, Ruan Min, Liu W |
The MDM2 T309G polymorphism and risk of lung cancer: an updated meta-analysis of 10,186 cases and 14,155 controls. Panminerva medica 2016 Dec 58 (4): 341-348. Tian Xiaodong, Wang Bo, Guo Juntang, Liu Xi, Zhang Tao, Liang Chaoyang, Zhou Naikang, Hou Xiaobin, Ma Yongfu, Yu Hua, Chen Lei, Ren Zhipeng, Fan Kaijie, Tian Qi |
Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals. Medicine 2016 Mar 95 (9): e2948. Zhuo Xianlu, Ye Huiping, Li Qi, Xiang Zhaolan, Zhang Xueyu |
Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis. Medicine 2016 Mar 95 (12): e2941. Ding Hui, Dai Yu, Ning Zhongyun, Fan Ning, Wang Zhiping, Li Pei, Zhang Liyuan, Tao Yan, Wang Hanzha |
Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis. Disease markers 2016 2016 4585484. Wang Ping, Wang Meilin, Li Sanqiang, Ma Lingjun, Xi Shoumin, He Ji |
Detection of nasopharyngeal carcinoma susceptibility with single nucleotide polymorphism analysis using next-generation sequencing technology. Oncotarget 2017 (32): 52708-52723. Wu Mu-Yun, Huang Shu-Jing, Yang Fan, Qin Xin-Tian, Liu Dong, Ding Ying, Yang Shu, Wang Xi-Che |
MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects. OncoTargets and therapy 2017 8 10 3773-3780. Hua Wenfeng, Zhang Anqi, Duan Ping, Zhu Jinhong, Zhao Yuan, He Jing, Zhang Z |
The MDM2 rs937283 A > G variant significantly increases the risk of lung and gastric cancer in Chinese population. International journal of clinical oncology 2018 May . Chen Bifeng, Wang Jieling, Chen Yucan, Gu Xiuli, Feng Xianho |
Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis. Medicine 2018 Dec 97 (49): e13273. Zou Xinwei, Zhang Yi, Zhang Lin, Li Jiaxi, Zhu Chenjie, Cheng Qiuhong, Zhou Jinhua, Chen Youg |
The 40bp indel polymorphism of MDM2 increase the risk of cancer: An updated meta-analysis. Molecular biology research communications 2019 Mar 8 (1): 1-8. Moazeni-Roodi Abdolkarim, Ghavami Saeid, Hashemi Mohamm |
Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis. Pathology, research and practice 2019 Jul 152538. Luan Lan, Wang Hongying, Zhao Beibei, Wang Fan, Shi Juan, Xu Xiaj |
A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population. The Korean journal of internal medicine 2020 May 35 (3): 672-681. Reza Hasan Al, Anamika Wardatul Jannat, Chowdhury Md Miraj Kobad, Mostafa Mohammad Golam, Uddin M Aft |
Genetic Polymorphisms and Platinum-Based Chemotherapy-Induced Toxicities in Patients With Lung Cancer: A Systematic Review and Meta-Analysis. Frontiers in oncology 2020 4 9 1573. Liu Wenhui, Wang Ying, Luo Jianquan, Yuan Haiyan, Luo Zhiyi |
Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies. Gene 2020 Jan 734 144391. Elshazli Rami M, Toraih Eman A, Elgaml Abdelaziz, Kandil Emad, Fawzy Manal |
Correlation between MDM2 T309G single nucleotide polymorphism and esophageal cancer susceptibility: An updated meta-analysis. Thoracic cancer 2020 Jan . Yin Lele, Shen Guo, Zhu B |
Association of Murine Double Minute 2 polymorphisms with gastric cancer: A systematic review with meta-analysis. Biomedical reports 2021 7 15 (2): 69. Timóteo Mafalda, Tavares Ana, Cruz Sara, Campos Carla, Medeiros Rui, Sousa Hu |
The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis. Vavilovskii zhurnal genetiki i selektsii 2021 5 24 (7): 777-784. Bulgakova O, Kussainova A, Bersimbaev |
Systematic Review and Meta-analysis of the Most Common Genetic Mutations in Esophageal Squamous Cell Carcinoma. Journal of gastrointestinal cancer 2021 Oct . Naseri Amirreza, Salehi-Pourmehr Hanieh, Majidazar Reza, Seraji Parya, Rezazadeh-Gavgani Erfan, Zehtabi Mojtaba, Kiani-Kezbin Hamed, Salehnia Fatemeh, Hassannezhad Sina, Hajikamanj Arash, Raeisi Morta |
Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review. Frontiers in oncology 2022 12 973077. Yu Meijia, Zhang Qin, Zhao X |
Systematic review and meta-analysis of genomic alterations in acral melanoma. Pigment cell & melanoma research 2022 3 35 (3): 369-386. Broit Natasa, Johansson Peter A, Rodgers Chloe B, Walpole Sebastian T, Hayward Nicholas K, Pritchard Antonia |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: